BamSEC and AlphaSense Join Forces
Learn More

Innovus Pharmaceuticals, Inc.

Formerly OTC: INNV

Material Contracts Filter

EX-10.1
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 8 pages Strictly Confidential
12/34/56
EX-10.2
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 12 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.43
from S-1/A 2 pages Strictly Confidential the Company and Rodman Hereby Agree to Amend the Engagement Agreement, as Follows: The Parties Hereby Clarify That Rodman Shall Not Be Entitled to Any Warrant Solicitation Fees Under Section A.1 of the Engagement Letter. Section A.2 Is Hereby Amended and Restated in Its Entirety to Read as Follows
12/34/56
EX-10.42
from S-1/A 8 pages Engagement Agreement
12/34/56
EX-10.1
from 8-K 13 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Amendment and Supplement
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.7
from S-1 7 pages First Amendment to Securities Purchase Agreement and Transaction Documents
12/34/56
EX-10.6
from S-1 6 pages June 24, 2016 Strictly Confidential
12/34/56
EX-10.5
from S-1 6 pages March 25, 2015 Innovus Pharmaceuticals, Inc. 9171 Towne Centre Drive, Suite 440, San Diego, Ca 92122 Att: Dr. Bassam Damaj, Chief Executive Officer Re: Engagement Agreement
12/34/56
EX-10.4
from S-1 11 pages Registration Rights Agreement
12/34/56
EX-10.3
from S-1 9 pages Innovus Pharmaceuticals, Inc. Common Stock Purchase Warrant
12/34/56
EX-10.2
from S-1 16 pages Convertible Promissory Note
12/34/56
EX-10.1
from S-1 23 pages Securities Purchase Agreement
12/34/56
EX-10.6
from S-1/A 6 pages March 25, 2015 Innovus Pharmaceuticals, Inc. 9171 Towne Centre Drive, Suite 440, San Diego, Ca 92122 Att: Dr. Bassam Damaj, Chief Executive Officer Re: Engagement Agreement
12/34/56
EX-10.6
from S-1/A 6 pages March 25, 2015 Innovus Pharmaceuticals, Inc. 9171 Towne Centre Drive, Suite 440, San Diego, Ca 92122 Att: Dr. Bassam Damaj, Chief Executive Officer Re: Engagement Agreement
12/34/56